Table 1.
EGFR inhibitor clinical trials for glioblastoma.
| Drug Name | Context | Impact |
|---|---|---|
| Gefitinib | Human glioblastoma clinical trial | Minimal to no activity [56] |
| Erlotinib | Human glioblastoma clinical trial | Minimal to no activity [58] |
| Afatinib | Human glioblastoma clinical trial | Minimal to no activity [55] |
| Lapatinib | Human glioblastoma clinical trial | Minimal to no activity [57] |
| Osimertinib | Human glioblastoma clinical trial | Minimal to no activity [53] |
| Cetuximab | Human glioblastoma clinical trial | Minimal to no activity [59] |
| Rindopepimut | Human glioblastoma clinical trial | Minimal to no activity [54] |
| Depatuxizumab mafodotin + TMZ | Human glioblastoma clinical trial | Minimal to no activity [52] |